Summit, a first-of-its-kind technology, received FDA clearance in January 2023. It combines a 4K single-use surgical arthroscope with the company’s cloud-based software Pristine Connect. The scope delivers a high-definition image every time, according to Pristine Surgical.
The single-use scope eliminates the need to buy expensive equipment and reduces hidden costs of maintenance contracts and sterilization. Reused scopes can often prove fragile and easily damaged, negatively affecting visualization, disrupting workflows and presenting unnecessary safety risks.
According to a news release, Pristine already kicked off its limited market release for Summit. Following that initial rollout, the company partnered with AcuityMD for a full-scale launch to ambulatory surgery centers (ASCs).
AcuityMD’s platform offers streamlined workflows with robust data to help sales teams build comprehensive strategies. The data-driven platform identified which surgeons had the most arthroscopic volume at ASCs and key opinion leaders, helping to bring Summit to a wider market. This quickly and reliably surfaced priority opportunities for Pristine, the companies say.
“AcuityMD has been invaluable in helping us discover which surgeons are performing procedures, where they are being done, and identifying high-volume regions where we need to selectively hire more reps,” said Dave Carey, chief commercial officer at Pristine Surgical. “The platform’s intuitive interface makes it easy to find granular data to support tactical outreach, as well as get a bird’s eye view to help make long-term strategic decisions for market expansion. What normally requires hours or months of research now takes us minutes with a few clicks.”
Pristine plans to use AcuityMD’s platform as an integral part of its sales and marketing efforts across its entire portfolio. It plans for market expansion into the laparoscopy and flexible endoscopy markets in 2025. The company says it intends to use AcuityMD’s platform to familiarize itself with the new markets and develop a smart commercialization strategy.
“Pristine Surgical is bringing an important medical innovation to the market and we are proud to help get their tech-enabled, single-use arthroscopes into as many surgeons’ hands as possible,” Michael Monovoukas, CEO and co-founder of AcuityMD said. “Working with six of the top 10 medtech organizations and over 200 mid-size to startup companies, we remain fiercely committed to accelerate the adoption of these powerful innovations widely for the benefit of all.”
